Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca.

Antimicrobial Agents and Chemotherapy
A MarcheseA Philippon

Abstract

Klebsiella oxytoca 1731, which showed a wide spectrum of resistance to beta-lactams, including cefoxitin, was isolated in 1994 from a patient in Genoa, Italy. This strain contained a plasmid-mediated AmpC beta-lactamase with a pI of 7.25. Sequencing of the corresponding DNA of K. oxytoca 1731 revealed 96 and 97% identities of the deduced amino acid sequence with FOX-1 and FOX-2, respectively.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 1, 1992·The Journal of Antimicrobial Chemotherapy·D J PayneS G Amyes
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jan 1, 1990·Antimicrobial Agents and Chemotherapy·J P Iaconis, C C Sanders
Jun 1, 1974·The Biochemical Journal·S G Waley
Mar 1, 1981·Journal of Bacteriology·C I Kado, S T Liu
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Mar 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A MarcheseA Philippon
Jan 1, 1996·Antimicrobial Agents and Chemotherapy·A BauernfeindH Giamarellou
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·A BauernfeindD Meyer

❮ Previous
Next ❯

Citations

Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Laura BriñasCarmen Torres
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Alain PhilipponGeorge A Jacoby
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·Laurent RaskineMarie-José Sanson-Le-Pors
Aug 9, 2002·Canadian Journal of Microbiology·Jan Walther-Rasmussen, Niels Høiby
May 6, 2015·International Journal of Molecular Sciences·Jeong Ho JeonSang Hee Lee
Jul 15, 2015·Antimicrobial Agents and Chemotherapy·Jae Jin LeeSang Hee Lee
Nov 16, 2013·The Journal of Antimicrobial Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Nov 12, 2003·Emerging Infectious Diseases·Guillem PratsLluís Salleras
Feb 15, 2018·Antimicrobial Agents and Chemotherapy·Michiyoshi NukagaRobert A Bonomo
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Mark D Reisbig, Nancy D Hanson
Jul 28, 2006·Journal of Perinatology : Official Journal of the California Perinatal Association·E FakiogluB C Herold
Feb 27, 1999·Antimicrobial Agents and Chemotherapy·S TrépanierA Huletsky
Jan 20, 2000·Antimicrobial Agents and Chemotherapy·G Bou, J Martínez-Beltrán
Oct 16, 2015·Antimicrobial Agents and Chemotherapy·Thouraya ChérifGuillaume Arlet
May 31, 2002·Journal of Clinical Microbiology·F Javier Pérez-Pérez, Nancy D Hanson
Sep 24, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jung Hun LeeSang Hee Lee
Dec 2, 2021·Clinical Microbiology Reviews·Jing YangZhiyong Zong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.